Your browser doesn't support javascript.
loading
A Case of Lung Abscess Caused by Double Immunosuppressive Therapy to Treat Ulcerative Colitis.
Tominaga, Keiichi; Kanazawa, Mimari; Tanaka, Takanao; Kojimahara, Shunsuke; Sugaya, Takeshi; Watanabe, Shoko; Yamamiya, Akira; Majima, Yuichi; Iijima, Makoto; Goda, Kenichi; Irisawa, Atsushi.
Affiliation
  • Tominaga K; Department of Gastroenterology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan.
  • Kanazawa M; Department of Gastroenterology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan.
  • Tanaka T; Department of Gastroenterology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan.
  • Kojimahara S; Department of Gastroenterology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan.
  • Sugaya T; Department of Gastroenterology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan.
  • Watanabe S; Department of Gastroenterology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan.
  • Yamamiya A; Department of Gastroenterology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan.
  • Majima Y; Department of Gastroenterology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan.
  • Iijima M; Department of Gastroenterology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan.
  • Goda K; Department of Gastroenterology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan.
  • Irisawa A; Department of Gastroenterology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan.
Medicina (Kaunas) ; 56(11)2020 Nov 07.
Article in En | MEDLINE | ID: mdl-33171752
A 25-year-old man was admitted to our institution for remission induction therapy to treat a 12-year condition of ulcerative colitis (UC). Previously, he was treated with drugs, such as mesalamine, immunomodulators, prednisolone (PSL), and anti-TNFα anti-body, but remission was not maintained. Therefore, we started remission induction therapy with 20 mg/day of tofacitinib (TOF) to inhibit the action of Janus kinase. On the 29th day after TOF administration, he developed a lung abscess with high fever. A chronic bulla was already present in his lung; therefore, the lung abscess was likely formed due to a combination of the bulla being present and the pharmacological effects of TOF. Our report is significant as it highlights the compounding association between TOF and PSL therapy and bulla presence with the rare adverse effect of developing an abscess.
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative / Lung Abscess Type of study: Etiology_studies Limits: Adult / Humans / Male Language: En Journal: Medicina (Kaunas) Journal subject: MEDICINA Year: 2020 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative / Lung Abscess Type of study: Etiology_studies Limits: Adult / Humans / Male Language: En Journal: Medicina (Kaunas) Journal subject: MEDICINA Year: 2020 Type: Article Affiliation country: Japan